Medpace Holdings - 8 Year Stock Price History | MEDP
- The all-time high Medpace Holdings stock closing price was 413.31 on March 21, 2024.
- The Medpace Holdings 52-week high stock price is 421.00, which is 6.3% above the current share price.
- The Medpace Holdings 52-week low stock price is 197.39, which is 50.1% below the current share price.
- The average Medpace Holdings stock price for the last 52 weeks is 286.49.
Medpace Holdings Historical Annual Stock Price Data | ||||||
---|---|---|---|---|---|---|
Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
2024 | 361.7249 | 305.5900 | 413.3100 | 284.8700 | 395.9300 | 29.17% |
2023 | 235.2818 | 208.2800 | 312.6800 | 174.3100 | 306.5300 | 44.31% |
2022 | 167.3194 | 214.3100 | 226.5700 | 130.2000 | 212.4100 | -2.40% |
2021 | 179.6718 | 134.4200 | 227.9000 | 132.0200 | 217.6400 | 56.35% |
2020 | 103.5964 | 82.9700 | 149.1900 | 61.7100 | 139.2000 | 65.60% |
2019 | 67.7122 | 52.4000 | 85.8900 | 49.3800 | 84.0600 | 58.81% |
2018 | 46.6866 | 37.1400 | 63.9800 | 32.0250 | 52.9300 | 45.97% |
2017 | 31.4778 | 35.9100 | 38.3100 | 22.1800 | 36.2600 | 0.53% |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Services | $12.076B | $1.886B |
Medpace Holdings, Inc. is a scientifically-driven, global, full-service clinical contract research organization which provides Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace Holdings, Inc. is headquartered in Cincinnati, Ohio. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Elevance Health (ELV) | United States | $125.431B | 15.74 |
Cencora (COR) | United States | $47.828B | 19.09 |
ICON (ICLR) | Ireland | $24.755B | 23.37 |
DiDi Global (DIDIY) | China | $23.950B | 0.00 |
Avantor (AVTR) | United States | $17.059B | 23.50 |
Viatris (VTRS) | United States | $13.760B | 3.93 |
CochLear (CHEOY) | $13.446B | 0.00 | |
Revvity (RVTY) | United States | $12.611B | 21.95 |
Charles River Laboratories (CRL) | United States | $11.735B | 21.39 |
EUROFINS SCIENT (ERFSF) | Luxembourg | $11.550B | 0.00 |
Natera (NTRA) | United States | $11.158B | 0.00 |
Solventum (SOLV) | United States | $10.666B | 0.00 |
Amplifon S.p.A (AMFPF) | Italy | $7.290B | 37.01 |
HealthEquity (HQY) | United States | $6.782B | 50.67 |
Bausch + Lomb (BLCO) | Canada | $5.187B | 19.95 |
Organon (OGN) | United States | $4.709B | 4.56 |
Doximity (DOCS) | United States | $4.401B | 32.76 |
PACS (PACS) | United States | $3.643B | 0.00 |
Sotera Health (SHC) | United States | $3.204B | 15.72 |
Surgery Partners (SGRY) | United States | $3.145B | 29.22 |
Progyny (PGNY) | United States | $3.124B | 52.42 |
GoodRx Holdings (GDRX) | United States | $2.797B | 141.60 |
Life Times (LTH) | United States | $2.776B | 30.67 |
Premier (PINC) | United States | $2.493B | 9.13 |
Teladoc Health (TDOC) | United States | $2.257B | 0.00 |
AMN Healthcare Services Inc (AMN) | United States | $2.131B | 6.89 |
Agilon Health (AGL) | United States | $2.109B | 0.00 |
BrightSpring Health Services (BTSG) | United States | $1.782B | 0.00 |
Agiliti (AGTI) | United States | $1.366B | 22.31 |
Establishment Labs Holdings (ESTA) | $1.333B | 0.00 | |
NovoCure (NVCR) | Jersey | $1.316B | 0.00 |
Alignment Healthcare (ALHC) | United States | $0.975B | 0.00 |
Pediatrix Medical (MD) | United States | $0.748B | 7.74 |
Embecta (EMBC) | United States | $0.599B | 3.95 |
Auna S.A (AUNA) | Luxembourg | $0.531B | 0.00 |
InnovAge Holding (INNV) | United States | $0.516B | 0.00 |
Enhabit (EHAB) | United States | $0.495B | 44.86 |
COMPASS Pathways (CMPS) | United Kingdom | $0.487B | 0.00 |
Sonida Senior Living (SNDA) | United States | $0.438B | 0.00 |
LifeMD (LFMD) | United States | $0.437B | 0.00 |
CareDx (CDNA) | United States | $0.391B | 0.00 |
Beauty Health (SKIN) | United States | $0.378B | 0.00 |
MultiPlan (MPLN) | United States | $0.368B | 0.00 |
DocGo (DCGO) | United States | $0.364B | 58.17 |
ModivCare (MODV) | United States | $0.340B | 4.51 |
Sera Prognostics (SERA) | United States | $0.335B | 0.00 |
GeneDx Holdings (WGS) | United States | $0.291B | 0.00 |
Sharecare (SHCR) | United States | $0.266B | 0.00 |
Ascend Wellness Holdings (AAWH) | United States | $0.256B | 0.00 |
Biodesix (BDSX) | United States | $0.145B | 0.00 |
So-Young (SY) | China | $0.123B | 41.33 |
Oncology Institute (TOI) | United States | $0.088B | 0.00 |
Pono Capital Two (PTWO) | United States | $0.076B | 0.00 |
IceCure Medical (ICCM) | Israel | $0.054B | 0.00 |
NeueHealth (NEUE) | United States | $0.052B | 0.00 |
Co-Diagnostics (CODX) | United States | $0.036B | 0.00 |
Nutex Health (NUTX) | United States | $0.032B | 0.00 |
Singular Genomics Systems (OMIC) | United States | $0.030B | 0.00 |
NeuroOne Medical Technologies (NMTC) | United States | $0.029B | 0.00 |
SeaStar Medical Holding (ICU) | United States | $0.027B | 0.00 |
DermTech (DMTK) | United States | $0.020B | 0.00 |
OncoCyte (OCX) | United States | $0.020B | 0.00 |
Aesthetic Medical Hldngs Group (AIH) | China | $0.015B | 0.00 |
BIMI Holdings (BIMI) | United States | $0.014B | 0.00 |
BioNexus Gene Lab (BGLC) | $0.011B | 0.00 | |
TRxADE HEALTH (MEDS) | United States | $0.009B | 0.00 |
XWELL (XWEL) | United States | $0.008B | 0.00 |
Intelligent Bio Solutions (INBS) | United States | $0.007B | 0.00 |
OpGen (OPGN) | United States | $0.007B | 0.00 |
Assure Holdings (IONM) | United States | $0.006B | 0.00 |
NewGenIvf Group (NIVF) | Singapore | $0.005B | 0.00 |
Aclarion (ACON) | United States | $0.003B | 0.00 |
ISpecimen (ISPC) | United States | $0.003B | 0.00 |